title: Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
authors: Renal Unit, Department of Medicine, Queen Elizabeth Hospital, SAR, Hong Kong, People's Republic of China.
authors: K M
authors: KM
authors: Wong
authors: C Y
authors: CY
authors: Cheung
authors: Y H
authors: YH
authors: Chan
authors: W L
authors: WL
authors: Chak
authors: K S
authors: KS
authors: Choi
authors: K F
authors: KF
authors: Chau
authors: C S
authors: CS
authors: Li
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D002102:Cadaver; D002423:Cause of Death; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000473:pathology; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D015996:Survival Rate; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D014019:Tissue Donors
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine; D016559:Tacrolimus